Updated Head Injury Guidelines Support Risk-Based CT and Observation Decisions
Posted on 17 Nov 2026
Head injuries are a common reason for emergency department visits, with most cases classified as mild. However, clinicians must identify patients at risk of intracranial bleeding or other serious injuries while avoiding unnecessary computed tomography scans and hospital admissions in low-risk cases. To support more individualized clinical decisions, researchers have developed updated Scandinavian guidelines for managing adults with minimal, mild, and moderate head injuries.
The updated 2026 guidelines from the Scandinavian Neurotrauma Committee were developed by researchers from several institutions, including Karolinska Institutet and Stockholm South General Hospital. The recommendations focus on the initial management of adults with minimal, mild, and moderate head injuries, revising the previous 2013 guidance to reflect an aging population, evolving use of antithrombotic therapies, and the emergence of new blood biomarkers for brain injury.
The updated guidelines emphasize assessing each patient’s overall risk profile when determining whether to perform head computed tomography (CT), initiate structured observation, or discharge without imaging. Under the new recommendations, anticoagulant therapy no longer automatically warrants a head CT scan but is evaluated alongside other risk factors, including age, suspected loss of consciousness, and repeated vomiting.
The recommendations were developed through a systematic review, meta-analysis, and modified Delphi consensus process. The evidence review included 110 studies examining the risk of traumatic intracranial injury and 33 studies assessing the need for emergency neurosurgical intervention. Following the review, 29 experts and stakeholders from Nordic countries participated in developing the guidance. The findings were published in The Lancet Regional Health – Europe,on November 7, 2026.
The guidelines also support structured observation as an alternative to immediate CT imaging for selected patients. A notable addition is the potential use of blood biomarkers, including GFAP and UCH-L1, to help identify patients who may safely avoid head CT scans. However, researchers acknowledge that the certainty of evidence remains limited for several recommendations, highlighting the need for further studies to validate the safety and effectiveness of the updated approach.
“We want to use head CT and clinical observation where they are most useful, while quickly identifying patients with signs of a more serious injury. The new guidelines make it possible to adapt the assessment to the patient's risk factors and to the resources available locally,” said Eric Thelin, associate professor and research group leader at the Department of Clinical Neuroscience, Karolinska Institutet.
Related Links
Karolinska Institutet